Pure Nad+ Nicotinamide Adenine Dinucleotide Powder CAS 53-84-9

Name: Pure Nad+ Nicotinamide Adenine Dinucleotide Powder CAS 53-84-9
Brand: Anhui GSH Bio-Technology Co., Ltd.
SKU: 1952894471

Anhui, ChinaAnhui GSH Bio-Technology Co., Ltd.

US$120.00

25 kg

Sample price:US$0.00/gram.Request sample

Product profile

Customization

Available

CAS No.

53-84-9

Formula

C21h27n7014p2

Model NO.

NAD+

EINECS

200-184-4

Type

Synthesis Material Intermediates

Appearance

Powder

Quality

Refined

Colour

White

Feature

Stocked, Eco-Friendly

Variety

Powder

Product Name

Beta Nicotinamide Adenine Dinucleotide

pH Value of Solution

2.0-5.0

Loss on Drying

No More Than 8%

Transport Package

1kg/Bag; 25kg/Barrel

Specification

Whiter or off-white crystalline

Trademark

Origin

China

HS Code

29389090

Production Capacity

10 Tons/Year

Company profile

Importers and ExportersHigh Repeat Buyers Choice100% Finished Products InspectionManagement Certification

Anhui GSH Bio-Technology Co., Ltd.

Anhui, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 8 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤3.61h

AI-Powered supplier vetting

SummaryAnhui Gute Biotechnology Co., Ltd., also identified as Anhui GSH Bio-Technology Co., Ltd., is a China-based manufacturing company established in 2017. It reports three production lines, production bases in Jilin and Anhui, a third base planned for construction in 2023, 20 years of combined R&D engineer experience, and 21–30 quality-control staff. Its listed products include glutathione, NMN, citicoline sodium, CoQ10, and related ingredients, with stated output for several products. The supplier reports ISO9001:2015 and applications for BRCGS, HALAL, KOSHER, FSSC, HACCP, and FDA-related certifications. An SGS audit record is valid from June 20, 2025 to June 19, 2026, but the provided audit result value is not interpretable as a performance conclusion. Overseas service, detailed R&D services, customization, sustainability systems, and customer cases remain insufficiently evidenced.

Supplier typeThe supplier is explicitly identified as a factory and manufacturing enterprise in Anhui, China, with production bases in Anhui and Jilin and an integrated R&D, production, and sales model. This supports classification as a direct manufacturer rather than a trading-only entity.

CertificationsThe supplier explicitly reports an ISO9001:2015 certificate and lists applications for BRCGS, HALAL, KOSHER, FSSC, HACCP, and FDA-related certificates. An SGS audit record is also shown as valid from June 20, 2025 to June 19, 2026, although the supplied audit result value does not establish the audit outcome.

R&D capabilityThe supplier describes integrated R&D, production, and sales, 14 years of R&D experience, 19 declared Chinese invention patents, 2 declared international invention patents, 7 authorized Chinese invention patents, and 8 software copyrights. Nevertheless, specific professional-technical R&D, 3D design, SDK, new-product, and ODM capabilities are marked unknown.

Production capacityThe supplier reports three production lines, major production bases in Jilin and Anhui, a third base planned to begin construction in April 2023, and product output figures for citicoline sodium, glutathione, and NMN. These records provide explicit evidence of established production capacity and multi-site operations.